SCHEMBL29391434

SCHEMBL29391434

COc1cc(OC)cc(-c2cc3cnc(NCCCN4CCN(CC(=O)OC(C)(C)C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 20/20 0.84
▸ FGFR2 P21802 16/20 0.84
▸ FGFR4 P22455 16/20 0.84
▸ FGFR3 P22607 16/20 0.84
▸ KDR P35968 11/20 0.84
▸ FLT1 P17948 10/20 0.84
▸ FLT4 P35916 10/20 0.84
▸ SRC P12931 3/20 0.65
▸ GLA P06280 1/20 0.65
▸ CSK P41240 1/20 0.65
▸ KMT2A Q03164 1/20 0.65
▸ ATM Q13315 1/20 0.65
▸ EGFR P00533 4/20 0.61
▸ PRKD3 O94806 1/20 0.59
▸ PRKCG P05129 1/20 0.59
▸ PRKCB P05771 1/20 0.59
▸ PRKCA P17252 1/20 0.59
▸ PRKCH P24723 1/20 0.59
▸ PRKCI P41743 1/20 0.59
▸ PRKCE Q02156 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22532497 1.00 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL29388286 0.94 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL22532573 0.94 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL22532398 0.92 FGFR1 (0.87) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL29391039 0.92 FGFR1 (0.87) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL22531580 0.91 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL29388070 0.91 FGFR1 (0.84) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL24490292 0.91 FGFR1 (1.00) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL19601461 0.90 FGFR1 (0.88) FGFR1FGFR2FGFR4FGFR3KDR
SCHEMBL22532348 0.89 FGFR1 (0.87) FGFR1FGFR2FGFR4FGFR3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3952863-A1 DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) Dana-Farber Cancer Institute, Inc. (US) 2022-02-16 — — EP disclosed
Send feedback